Sidse Ehmsen
8PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jul 15, 2022
Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy.Shijun Ma, Yue Zhao, Wee Chyan Lee
|Sep 17, 2021
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.Carla L Alves, Sidse Ehmsen, Mikkel G Terp
|Aug 26, 2021
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer.Carla L Alves, Sidse Ehmsen, Mikkel G Terp
|Mar 01, 2021
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study.S Ehmsen, L H Jakobsen, M E Lendorf
|Nov 19, 2020
Signaling pathways essential for triple-negative breast cancer stem-like cells.Sidse Ehmsen, Henrik J Ditzel
|Nov 19, 2020
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy.Yi Bao, Gokce Oguz, Wee Chyan Lee
Pageof 2
Frequent Collaborators
7 joint publications
Henrik J Ditzel
2 joint publications
Elgene Lim
2 joint publications
Martin Bak
2 joint publications
Odd L Gammelgaard
2 joint publications
Martina Tuttolomondo
2 joint publications
Qiang Yu
2 joint publications
Carla L Alves
1 joint publications
A Glenthøj
1 joint publications
J Ryg
1 joint publications
Qingfeng Chen
